Wockhardt

Showing the single result

Showing the single result

Wockhardt Limited is an Indian pharmaceutical and biotechnology company with its head office in Mumbai, Maharashtra, India. Founded by Dr. Habil Khorakiwala in the 1960s, Wockhardt has a presence in the fields of Pharmaceuticals, Biotechnology, Active Pharmaceutical Ingredients (APIs) and Super Speciality Hospitals. The company has full-fledged operations in India, USA, UK, Ireland and France, and a marketing presence in emerging markets like Russia, Brazil, Mexico, Vietnam, Philippines, Nigeria, Kenya, Ghana, Tanzania, Uganda, Nepal, Myanmar, Sri Lanka, Mauritius, Lebanon and Kuwait.

Wockhardt is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world. It is India’s leading research-based global healthcare enterprise with relevance in the fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.

Wockhardt is a true Indian Multi-National Company with a multi-ethnic workforce of 8600 Wockhardt Associates from 21 different nationalities globally. It has 3 research centers and 12 manufacturing plants, with businesses ranging from the manufacture and marketing of Pharmaceutical and Bio-pharmaceutical formulations, Active Pharmaceutical Ingredients (APIs) and Vaccines.

Wockhardt is a business in transition. New and innovative business models are in motion to make the most of emerging opportunities. A new drive for growth today permeates every mindset, process, and techno-innovation within Wockhardt.

At Wockhardt, we are looking at new ways of thinking, new ways of working and new ways to touch people’s lives.